While our ability to collect large amounts of experimental data in a timely and cost-effective manner represented, until recently, a top priority, a different challenge is currently taking shape. Now ...

NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...

CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the commercial launch of the PhysioMimix™ ...

The POSTECH-Catholic University Medical Biotechnology Research Institute, which has led the convergence research of domestic ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company unlocking the human body’s own power to cure disease, today unveiled $4.3 million in seed funding. The investment capital has enabled ...

Intelligent Bio Solutions (INBS) provided an update on its FDA 510(k) clearance process for its Intelligent Fingerprinting Drug Screening System.

Peptide mapping analysis of protein digestions is a critical component of biopharmaceutical development and manufacturing. The demanding method conditions required to perform these complex separations ...

Intelligent Bio Solutions Inc. (INBS) has submitted a 510(k) premarket notification to the FDA for its Intelligent Fingerprinting Drug Screening System, a rapid and non-invasive drug testing method ...

Biopharmaceutical companies are often progressing several monoclonal antibody (mAb) drug candidates to mitigate the risks associated with drug development. This strategic approach, aimed at increasing ...

The drug-testing system screens fingerprint sweat for recent use of drugs, returning results in under ten minutes, the New York company said. Intelligent Bio said it is currently evaluating the FDA's ...

Feb 19 (Reuters) - Diagnostics company Bio-Rad (BIO.N), opens new tab has been sued by the California Institute of Technology for allegedly misusing the school's patented technology for analyzing ...